MSG Entertainment Q2 Earnings: Strong Holiday Ticket Sales, Beats Revenue Estimates Despite Concert Decline

Benzinga
02-06

Madison Square Garden Entertainment Corp (NYSE:MSGE) reported its fiscal second-quarter 2025 results Thursday.

Revenue grew by 1% year-on-year to $407.42 million, beating the analyst consensus estimate of $401.76 million. 

EPS of $1.56 missed the analyst consensus estimate of $2.16.

Also Read: Harley-Davidson Struggles With Sales Drop In Q4, But New Touring Models Boost Market Share

In its 91st holiday season, the company sold approximately 1.1 million tickets across 200 shows, compared to over 1 million tickets sold over 193 last season.

Revenues from entertainment offerings remained firm year-on-year at $318.28 million, primarily due to lower event-related revenues, which were largely offset by an increase in revenues from the Christmas Spectacular production and higher revenues. 

Food, beverage and merchandise revenues increased 1% Y/Y to $59.3 million due to more Knicks and Rangers games played at The Garden and additional Christmas Spectacular performances. Three more Knicks and Rangers and the two additional Christmas performances were partially offset by lower food and beverage sales at concerts.

Event-related revenues decreased by $22.5 million due to lower concert revenues.

In addition, the company reported an adjusted operating income of $164.0 million, versus $160.1 million a year ago, primarily due to lower direct operating expenses and higher revenues, partially offset by higher selling, general and administrative expenses. 

As of December 31, cash and equivalents stood at $55.2 million.

Madison Square Garden Entertainment stock gained 4% in the last 12 months. At least three Wall Street analysts cut their price targets on the stock after the dismal first-quarter print.

Price Action: MSGE stock was up 0.39% to $36.00 premarket at last check Thursday.

Also Read:

  • Fiserv Q4 Earnings: Merchant, Financial Solutions Fuel Growth, Double-Digit Outlook For 2025

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10